ISPOR OUTLINES NEW STRATEGIC VISION AT 18th ANNUAL EUROPEAN CONGRESS

Published Nov 10, 2015

ISPOR UPDATES STRATEGY IN ITS 20th ANNIVERSARY YEAR 

Milan, Italy—November 10, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) outlined the organization’s updated strategic vision this morning during its member meeting at the 18th Annual European Congress in Milan, Italy. ISPOR President Daniel C. Malone, RPh, PhD and CEO Nancy Berg presented ISPOR’s new organizational strategy, an update of ISPOR’s Vision 2020, the current strategic plan. ISPOR’s new Mission Statement to promote health economics and outcomes research excellence to improve decision making for health globally is supported by five strategic pillars:
  1. Scientific and Research Excellence
  2. Member Engagement
  3. Education and Training
  4. Communication and Collaboration
  5. Organizational Values
“We are very excited to introduce ISPOR’s new strategic vision to our members,” noted Berg. “Our updated strategy was developed by ISPOR’s Strategic Planning Working Group and approved by the ISPOR Board with input from many members.” In his comments, Malone emphasized the Society’s commitment to strengthen the integrity, advancement, and understanding of health economics and outcomes research globally. Additional information on ISPOR’s updated strategic vision may be found at http://www.ispor.org/mission.asp. ISPOR’s 18th Annual European Congress may be followed on social media using the hashtag #ISPORMilan.

###

Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

ISPOR Announces 2026-2027 Board of Directors

May 26, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research announced its 2026-2027 board of directors who will assume office on July 1, 2026.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×